Milk-derived bioactive peptides inhibit human endothelial-monocyte interactions via PPAR-γ dependent regulation of NF-κB

Journal of Inflammation (United Kingdom)

Volumn 12, Issue 1, 2015, Pages

  Marcone, Simone ^a   Haughton, Karen ^a   Simpson, Paul J ^b   Belton, Orina ^a   Fitzgerald, Desmond J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b TEAGASC   (Ireland)

Author keywords

Atherosclerosis; Inflammation; Milk derived bioactive peptides; NF B; PPAR

Indexed keywords

CASEIN HYDROLYSATE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TROGLITAZONE; VASCULAR CELL ADHESION MOLECULE 1;

ANTIINFLAMMATORY ACTIVITY; AORTIC ENDOTHELIAL CELL; ARTICLE; BACTERIAL FERMENTATION; CELL ADHESION; CELL INTERACTION; CELL VIABILITY; CHEMICAL PARAMETERS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; FERMENTATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MILK; MOLECULAR DYNAMICS; MONOCYTE; PEPTIDE SIZE DISTRIBUTION; PHENOTYPE; PROTEIN EXPRESSION;

EID: 84987800315     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/s12950-014-0044-1     Document Type: Article

References (67)

1. Tousoulis D, Kampoli AM, Papageorgiou N, Androulakis E, Antoniades C, Toutouzas K, et al. Pathophysiology of atherosclerosis: the role of inflammation. Curr Pharm Des. 2011; 17: 4089-110.
2. Mizuno Y, Jacob RF, Mason RP. Inflammation and the development of atherosclerosis. J Atheroscler Thromb. 2011; 18: 351-8.
3. Anogeianaki A, Angelucci D, Cianchetti E, D'Alessandro M, Maccauro G, Saggini A, et al. Atherosclerosis: a classic inflammatory disease. Int J Immunopathol Pharmacol. 2011; 24: 817-25.
4. Tremblay A, Gilbert JA. Milk products, insulin resistance syndrome and type 2 diabetes. J Am Coll Nutr. 2009; 28 Suppl 1: 91S-102S.
5. Elwood PC, Pickering JE, Givens DI, Gallacher JE. The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids. 2010; 45: 925-39.
6. Schanbacher FL, Talhouk RS, Murray FA. Biology and origin of bioactive peptides in milk. Livest Prod Sci. 1997; 50: 105-23.
7. Korhonen H, Pihlanto A. Technological options for the production of health-promoting proteins and peptides derived from milk and colostrum. Curr Pharm Des. 2007; 13: 829-43.
8. Hayes M, Stanton C, Fitzgerald GF, Ross RP. Putting microbes to work: dairy fermentation, cell factories and bioactive peptides. Part II: bioactive peptide functions. Biotechnol J. 2007; 2: 435-49.
9. Yamamoto N, Akino A, Takano T. Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. J Dairy Sci. 1994; 77: 917-22.
10. Lahov E, Regelson W. Antibacterial and immunostimulating casein-derived substances from milk: casecidin, isracidin peptides. Food Chem Toxicol: Int J Publ Br Ind Biol Res Assoc. 1996; 34: 131-45.
11. Dziuba J, Minkiewicz P, Nalecz D, Iwaniak A. Database of biologically active peptide sequences. Die Nahrung. 1999; 43: 190-5.
12. Malkoski M, Dashper SG, O'Brien-Simpson NM, Talbo GH, Macris M, Cross KJ, et al. Kappacin, a novel antibacterial peptide from bovine milk. Antimicrob Agents Chemother. 2001; 45: 2309-15.
13. Malinowski J, Klempt M, Clawin-Radecker I, Lorenzen PC, Meisel H. Identification of a NFkappaB inhibitory peptide from tryptic beta-casein hydrolysate. Food Chem. 2014; 165: 129-33.
14. Gaudel C, Nongonierma AB, Maher S, Flynn S, Krause M, Murray BA, et al. A whey protein hydrolysate promotes insulinotropic activity in a clonal pancreatic beta-cell line and enhances glycemic function in ob/ob mice. J Nutr. 2013; 143: 1109-14.
15. Jakala P, Pere E, Lehtinen R, Turpeinen A, Korpela R, Vapaatalo H. Cardiovascular activity of milk casein-derived tripeptides and plant sterols in spontaneously hypertensive rats. J Physiol Pharmacol: Off J Pol Physiol Soc. 2009; 60: 11-20.
16. Sipola M, Finckenberg P, Santisteban J, Korpela R, Vapaatalo H, Nurminen ML. Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J Physiol Pharmacol: Off J Pol Physiol Soc. 2001; 52: 745-54.
17. Hirota T, Ohki K, Kawagishi R, Kajimoto Y, Mizuno S, Nakamura Y, et al. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme. Hypertens Res: Off J Jpn Soc Hypertens. 2007; 30: 489-96.
18. Kruth HS Lipoprotein cholesterol and atherosclerosis. Curr Mol Med. 2001; 1: 633-53.
19. Le Brocq M, Leslie SJ, Milliken P, Megson IL. Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications, and therapeutic opportunities. Antioxid Redox Signal. 2008; 10: 1631-74.
20. Kuschert GS, Coulin F, Power CA, Proudfoot AE, Hubbard RE, Hoogewerf AJ, et al. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry. 1999; 38: 12959-68.
21. Rao RM, Yang L, Garcia-Cardena G, Luscinskas FW. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ Res. 2007; 101: 234-47.
22. Sasaki M, Jordan P, Welbourne T, Minagar A, Joh T, Itoh M, et al. Troglitazone, a PPAR-gamma activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-alpha. BMC Physiol. 2005; 5: 3.
23. Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res: Off J Eur Histamine Res Soc. 2000; 49: 497-505.
24. Daynes RA, Jones DC. Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol. 2002; 2: 748-59.
25. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, et al. The nuclear receptor superfamily: the second decade. Cell. 1995; 83: 835-9.
26. Hsueh WA, Jackson S, Law RE. Control of vascular cell proliferation and migration by PPAR-gamma: a new approach to the macrovascular complications of diabetes. Diabetes Care. 2001; 24: 392-7.
27. Chen NG, Han X. Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium. Biochem Biophys Res Commun. 2001; 282: 717-22.
28. Jackson SM, Parhami F, Xi XP, Berliner JA, Hsueh WA, Law RE, et al. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscler Thromb Vasc Biol. 1999; 19: 2094-104.
29. Neve BP, Fruchart JC, Staels B. Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis. Biochem Pharmacol. 2000; 60: 1245-50.
30. Pasceri V, Wu HD, Willerson JT, Yeh ET. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation. 2000; 101: 235-8.
31. Mestas J, Ley K. Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med. 2008; 18: 228-32.
32. Sanz MJ, Albertos F, Otero E, Juez M, Morcillo EJ, Piqueras L. Retinoid X receptor agonists impair arterial mononuclear cell recruitment through peroxisome proliferator-activated receptor-gamma activation. J Immunol. 2012; 189: 411-24.
33. Gao M, Hu Z, Zheng Y, Zeng Y, Shen X, Zhong D, et al. Peroxisome proliferator-activated receptor gamma agonist troglitazone inhibits high mobility group box 1 expression in endothelial cells via suppressing transcriptional activity of nuclear factor kappaB and activator protein 1. Shock. 2011; 36: 228-34.
34. Safaya S, Steinberg MH, Klings ES. Monocytes from sickle cell disease patients induce differential pulmonary endothelial gene expression via activation of NF-kappaB signaling pathway. Mol Immunol. 2012; 50: 117-23.
35. Auldist MJ, Johnston KA, White NJ, Fitzsimons WP, Boland MJ. A comparison of the composition, coagulation characteristics and cheesemaking capacity of milk from Friesian and Jersey dairy cows. J Dairy Res. 2004; 71: 51-7.
36. Ostersen S, Foldager J, Hermansen JE. Effects of stage of lactation, milk protein genotype and body condition at calving on protein composition and renneting properties of bovine milk. J Dairy Res. 1997; 64: 207-19.
37. Auldist MJ, Walsh BJ, Thomson NA. Seasonal and lactational influences on bovine milk composition in New Zealand. J Dairy Res. 1998; 65: 401-11.
38. Verdi RJ, Barbano DM, Dellavalle ME, Senyk GF. Variability in true protein, casein, nonprotein nitrogen, and proteolysis in high and low somatic cell milks. J Dairy Sci. 1987; 70: 230-42.
39. Martin P, Szymanowska M, Zwierzchowski L, Leroux C. The impact of genetic polymorphisms on the protein composition of ruminant milks. Reprod Nutr Dev. 2002; 42: 433-59.
40. Pihlanto A, Korhonen H. Bioactive peptides and proteins. Adv Food Nutr Res. 2003; 47: 175-276.
41. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997; 336: 1117-24.
42. Pfeuffer M, Schrezenmeir J. Bioactive substances in milk with properties decreasing risk of cardiovascular diseases. Br J Nutr. 2000; 84 Suppl 1: S155-9.
43. Phelan M, Kerins D. The potential role of milk-derived peptides in cardiovascular disease. Food Funct. 2011; 2: 153-67.
44. Bae S, Kim H, Lee N, Won C, Kim HR, Hwang YI, et al. alpha-Enolase expressed on the surfaces of monocytes and macrophages induces robust synovial inflammation in rheumatoid arthritis. J Immunol. 2012; 189: 365-72.
45. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto Jr AM, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 1997; 96: 4219-25.
46. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 1998; 351: 88-92.
47. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007; 115: 1285-95.
48. Rius C, Abu-Taha M, Hermenegildo C, Piqueras L, Cerda-Nicolas JM, Issekutz AC, et al. Trans-but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-kappaB activation and peroxisome proliferator-activated receptor-gamma upregulation. J Immunol. 2010; 185: 3718-27.
49. Magnani M, Crinelli R, Bianchi M, Antonelli A. The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB). Curr Drug Targets. 2000; 1: 387-99.
50. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem. 1999; 274: 30353-6.
51. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature. 2000; 403: 103-8.
52. Wilmer WA, Dixon C, Lu L, Hilbelink T, Rovin BH. A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARgamma. Biochem Biophys Res Commun. 2001; 281: 57-62.
53. Perez-Sala D, Cernuda-Morollon E, Canada FJ. Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Delta 12,14-prostaglandin J2. J Biol Chem. 2003; 278: 51251-60.
54. Hartmann R, Meisel H. Food-derived peptides with biological activity: from research to food applications. Curr Opin Biotechnol. 2007; 18: 163-9.
55. Meisel H. Biochemical properties of regulatory peptides derived from milk proteins. Biopolymers. 1997; 43: 119-28.
56. Meisel H. Multifunctional peptides encrypted in milk proteins. Biofactors. 2004; 21: 55-61.
57. Meisel H, FitzGerald RJ. Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects. Curr Pharm Des. 2003; 9: 1289-95.
58. Andrioli G, Ortolani R, Fontana L, Gaino S, Bellavite P, Lechi C, et al. Study of platelet adhesion in patients with uncomplicated hypertension. J Hypertens. 1996; 14: 1215-21.
59. Hernandez R, Carvajal AR, Armas-de Hernandez MJ, Guerrero-Pajuelo J, Armas-Padilla MC, Barragan O, et al. The effects of the calcium antagonist amlodipine on blood pressure and platelet aggregation in hypertensive patients. Postgrad Med J. 1991; 67 Suppl 5: S38-40.
60. Chabance B, Jolles P, Izquierdo C, Mazoyer E, Francoual C, Drouet L, et al. Characterization of an antithrombotic peptide from kappa-casein in newborn plasma after milk ingestion. Br J Nutr. 1995; 73: 583-90.
61. Karaki H, Doi K, Sugano S, Uchiwa H, Sugai R, Murakami U, et al. Antihypertensive effect of tryptic hydrolysate of milk casein in spontaneously hypertensive rats. Comp Biochem Physiol C, Comp Pharmacol Toxicol. 1990; 96: 367-71.
62. Aziz A, Anderson GH. Exendin-4, a GLP-1 receptor agonist, interacts with proteins and their products of digestion to suppress food intake in rats. J Nutr. 2003; 133: 2326-30.
63. Maeno M, Yamamoto N, Takano T. Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. J Dairy Sci. 1996; 79: 1316-21.
64. Masuda O, Nakamura Y, Takano T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr. 1996; 126: 3063-8.
65. Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr. 1996; 64: 767-71.
66. Erdmann K, Grosser N, Schipporeit K, Schroder H. The ACE inhibitory dipeptide Met-Tyr diminishes free radical formation in human endothelial cells via induction of heme oxygenase-1 and ferritin. J Nutr. 2006; 136: 2148-52.
67. Jauhiainen T, Ronnback M, Vapaatalo H, Wuolle K, Kautiainen H, Groop PH, et al. Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects. Eur J Clin Nutr. 2010; 64: 424-31.